• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Bicycle Therapeutics plc

    < Previous 1 2 Next >
    Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Participate in Upcoming Investor Conferences
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Participate in Upcoming Investor Conferences
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Participate in Upcoming Investor Conferences
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Participate in Upcoming Investor Conferences
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    Bicycle Therapeutics to Participate in the TD Cowen Radiopharmaceutical Innovation Summit
    From Bicycle Therapeutics plc
    Via Business Wire
    Tickers BCYC
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.